ABSTRACT
OBJECTIVE: To assess drug treatment compliance in institutionalised elderly patients, identifying reasons for poor compliance and introducing measures to reduce its prevalence. METHOD: A programme was designed to improve drug treatment compliance in geriatric patients in residential homes. Drug intervention consisted of using an educational technique of a mixed nature (verbal information with written back up). A data collection sheet was designed following a review of the literature. This was carried out by means of a clinical interview and by checking for tablets which were not taken. RESULTS: A total of 62 patients were chosen for drug management at a health and welfare centre in Alicante and 140 interventions were performed (2.8 interventions per patient). Compliance improved and there were significant differences in the variable for distrust due to lack of information (p = 0.009) and almost significant differences in the variable for better understanding of the dispensing system (p = 0.058). Duplicate treatment of the patients was eliminated in all cases after the pharmaceutical intervention. CONCLUSIONS: Our study suggests that pharmacist intervention in the drug management of geriatric patients can lead to improved treatment compliance, with the added benefits of improved knowledge of the medication and a reduction in possible drug-related problems.
Subject(s)
Drug Therapy , Geriatrics , Patient Compliance/statistics & numerical data , Aged , Aged, 80 and over , Female , Humans , MaleABSTRACT
OBJECTIVE: To assess an interdisciplinary follow-up programme for institutionalised elderly people on oral anticoagulant treatment. METHOD: The proposed follow-up treatment is of an interdisciplinary nature and includes INR, an interview with the patient and/or carer and an assessment of the treatment plan every week. The quality of drug treatment is assessed by the percentage of time and the percentage of measurements falling within the therapeutic range. The suitability of the programme in comparison to the traditional follow-up was studied in terms of the different proportions for the first variable and by analysing contingency tables for the second. RESULTS: Nine patients were recruited. Six patients (67%) showed a significant increase in the percentage of time they remained within the therapeutic range. 68.5% of INR measurements during the follow-up programme were within therapeutic range. The percentage of INR measurements below the therapeutic range was significantly reduced when compared to the traditional follow up. Thirteen pharmaceutical interventions were documented per patient. CONCLUSIONS: The complexity of oral anticoagulant treatment, the large number of interventions carried out together with elderly patients poor treatment compliance are evidence of the need to introduce follow-up programmes which include the professionals responsible for the patients care.
Subject(s)
Anticoagulants/administration & dosage , Institutionalization , Program Evaluation , Administration, Oral , Aged , Follow-Up Studies , Humans , Patient Care TeamABSTRACT
Objetivo: Evaluar la adherencia al tratamiento farmacológico en el grupo de población anciana institucionalizada, identificar las causas de falta de adherencia e implantar medidas que reduzcan su prevalencia. Método: Se diseñó un programa de mejora en la adherencia al tratamiento farmacológico en residentes geriátricos. La intervención farmacéutica consistió en una técnica educativa de carácter mixto: información oral más refuerzo escrito. Se diseñó una hoja de recogida de datos tras revisión bibliográfica. Se llevó a cabo mediante una entrevista clínica y comprobación de comprimidos no tomados. Resultados: Se implantó en 62 pacientes válidos para la gestión de la medicación de un centro sociosanitario de Alicante y se realizaron 140 intervenciones (2,8 intervenciones por paciente). Se mejoró la adherencia obteniendo diferencias significativas en la variable desconfianza por falta de información (p = 0,009) y prácticamente significativas en la mejora de la comprensión del sistema de dispensación (p = 0,058). La duplicidad en los tratamientos de los pacientes se logró eliminar en todos los casos tras la intervención farmacéutica. Conclusiones: Nuestro estudio sugiere que la intervención de un farmacéutico en el manejo de pacientes geriátricos puede producir una mejora de la adherencia al tratamiento, con los consiguientes beneficios añadidos de una mejora en el conocimiento de la medicación y la reducción de posibles problemas relacionados con los medicamentos
Objective: To assess drug treatment compliance in institutionalised elderly patients, identifying reasons for poor compliance and introducing measures to reduce its prevalence. Method: A programme was designed to improve drug treatment compliance in geriatric patients in residential homes. Drug intervention consisted of using an educational technique of a mixed nature (verbal information with written back up). A data collection sheet was designed following a review of the literature. This was carried out by means of a clinical interview and by checking for tablets which were not taken. Results: A total of 62 patients were chosen for drug management at a health and welfare centre in Alicante and 140 interventions were performed (2.8 interventions per patient). Compliance improved and there were significant differences in the variable for distrust due to lack of information (p = 0.009) and almost significant differences in the variable for better understanding of the dispensing system (p = 0.058). Duplicate treatment of the patients was eliminated in all cases after the pharmaceutical intervention. Conclusions: Our study suggests that pharmacist intervention in the drug management of geriatric patients can lead to improved treatment compliance, with the added benefits of improved knowledge of the medication and a reduction in possible drugrelated problems
Subject(s)
Male , Female , Aged , Humans , Health of the Elderly , Patient Compliance/statistics & numerical data , Treatment Refusal/statistics & numerical data , Health Services for the Aged/statistics & numerical data , Drug Dispensaries , Prevalence , Diuretics/administration & dosage , Antidepressive Agents/administration & dosage , Platelet Aggregation Inhibitors/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Patient Dropouts/statistics & numerical dataABSTRACT
en el anciano institucionalizado en tratamiento con anticoagulantes orales. Método: El programa de seguimiento propuesto tiene carácter interdisciplinar e incluye la determinación de INR, una entrevista con el paciente y/o cuidador y la valoración del plan terapéutico con una periodicidad semanal. La calidad farmacoterapéutica se ha valorado mediante el porcentaje de tiempo y el porcentaje de determinaciones en rango terapéutico. La idoneidad del programa, con respecto al seguimiento tradicional, se ha estudiado a través de la diferencia de proporciones para la primera variable y a través del análisis por tablas de contingencia para la segunda. Resultados: Se incluyen nueve pacientes. Seis de los nueve pacientes (67%) presentaron un aumento significativo en el porcentaje de tiempo en rango terapéutico. El 68,5% de las determinaciones de INR durante el programa de seguimiento se sitúan en rango terapéutico. El porcentaje de determinaciones de INR inferiores al rango terapéutico se redujo significativamente con respecto al seguimiento tradicional. Se han documentado 13 actuaciones por paciente. Conclusiones: La complejidad del tratamiento anticoagulante oral, el elevado número de actuaciones realizadas junto con la baja adherencia al tratamiento en pacientes ancianos, pone de manifiesto la necesidad de instaurar programas de seguimiento que cuenten con la participación de los profesionales encargados del cuidado del paciente
Objective: To assess an interdisciplinary follow-up programme for institutionalised elderly people on oral anticoagulant treatment. Method: The proposed follow-up treatment is of an interdisciplinary nature and includes INR, an interview with the patient and/or carer and an assessment of the treatment plan every week. The quality of drug treatment is assessed by the percentage of time and the percentage of measurements falling within the therapeutic range. The suitability of the programme in comparison to the traditional follow-up was studied in terms of the different proportions for the first variable and by analysing contingency tables for the second. Results: Nine patients were recluted. Six patients (67%) showed a significant increase in the percentage of time they remained within the therapeutic range. 68.5% of INR measurements during the follow-up programme were within therapeutic range. The percentage of INR measurements below the therapeutic range was significantly reduced when compared to the traditional follow up. Thirteen pharmaceutical interventions were documented per patient. Conclusions: The complexity of oral anticoagulant treatment, the large number of interventions carried out together with elderly patients poor treatment compliance are evidence of the need to introduce follow-up programmes which include the professionals responsible for the patients care
Subject(s)
Male , Female , Aged , Humans , Follow-Up Studies , Anticoagulants/pharmacology , Acenocoumarol/pharmacology , Health of the Elderly , Anticoagulants/administration & dosage , Administration, Oral , Patient Care Team , Acenocoumarol/administration & dosage , Health Services for the AgedABSTRACT
El objetivo del presente trabajo es evaluar la actividad científica y consumo de información de la revista Farmacia Hospitalaria mediante un análisis bibliométrico secuencial de los artículos originales publicados durante los últimos seis años. El material de este estudio está constituido por los artículos publicados en la sección de originales de la revista Farmacia Hospitalaria, calculándose los indicadores de producción, circulación, dispersión, consumo de información y repercusión. Se analizaron 143 originales y 2.823 referencias bibliográficas. El número de autores por original fue de 5,3 y las referencias por original de 19,7, con un porcentaje de autocitación bajo (3,1 por ciento).Las principales comunidades productoras fueron la Comunidad Valenciana y Cataluña, con más del 50 por ciento de los originales publicados. Predominaron las citas a artículos de revista (75 por ciento) y libros (14 por ciento). El tiempo transcurrido desde la recepción del original hasta su publicación fue de 147 días. En conclusión, los originales publicados en la revista Farmacia Hospitalaria mostraron unos indicadores similares a los obtenidos en otras revistas del mismo entorno. El consumo de información procede, fundamentalmente, de artículos de revistas. Las más citadas fueron el American Journal of Health-System Pharmacy y Farmacia Hospitalaria. Debido al decalaje entre la fecha de publicación de la revista y la fecha de recepción sería recomendable una mayor agilización del proceso editorial (AU)
